Microbiology of human immunodeficiency virus anorectal disease.
OBJECTIVE
Individuals who are seropositive for the human immunodeficiency virus are at high risk for opportunistic infection and anorectal disorders. Little prospective information is available regarding anorectal pathogens in these patients.


METHODS
One hundred sixty-three HIV-seropositive patients presented to the colorectal clinic between 1989 and 1992. Forty-seven (29 percent) patients were thought to have an infectious process and were prospectively studied using a standardized multiculture protocol.


RESULTS
Mean age was 33 (range, 19-59) years. All were male; high-risk behavior accounted for 87 percent of HIV transmissions. Presenting complaints included anorectal pain (79 percent), pus per anum (28 percent), and blood per anum (26 percent). Examination revealed perianal tenderness (60 percent), condyloma (38 percent), perianal ulcers (38 percent), and anal fissures (34 percent). Sixty-six sets of cultures were performed; 28 patients had one set, 15 had two sets, and 4 had three sets. Thirty-two of these 47 patients (68 percent) had positive cultures including herpes (50 percent), cytomegalovirus (25 percent), Neisseria gonorrhoeae (16 percent), chlamydia (16 percent), acidfast bacilli (2 percent), and others (9 percent). Six of 32 patients with positive cultures had more than one organism cultured. Sixteen (50 percent) patients with positive cultures were treated medically, 8 (25 percent) were treated surgically and 8 (25 percent) were treated with both modalities. Sixty-one procedures were performed on 17 patients for condylomata. Eighteen patients had 20 procedures for abscesses, 50 percent of whom had positive cultures for other than common bowel flora; all improved. Fourteen patients underwent 33 procedures for perianal fistulas. Mycobacterium fortuitum was cultured from one patient who required 13 procedures for abscesses and fistulas. Forty-five (96 percent) patients were followed for an average of 12.5 months +/- 2.9 SEM (range, 1-94 months). Symptoms were improved or resolved in 22 of 32 (69 percent) patients with positive cultures and in 11 of 13 (84 percent) with negative cultures.


CONCLUSIONS
Specific pathogens may often be identified in human immunodeficiency virus-seropositive patients with anorectal disorders if aggressively sought. Although patients without specific pathogens identified may be expected to improve with planned empiric treatment, positive identification allows more directed therapy.
Goldberg
G S
GS
Department of Surgery, George Washington University Medical Center, Washington, D.C.
Orkin
B A
BA
Smith
L E
LE
D000212:Acyclovir / Q000627:therapeutic use; D000328:Adult; D001004:Anus Diseases / Q000150:complications / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D002689:Chlamydia / Q000302:isolation & purification; D003131:Combined Modality Therapy; D003587:Cytomegalovirus / Q000302:isolation & purification; D006679:HIV Seropositivity / Q000150:complications / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009161:Mycobacterium / Q000302:isolation & purification; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification; D009894:Opportunistic Infections / Q000150:complications / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D011446:Prospective Studies; D012002:Rectal Diseases / Q000150:complications / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D012309:Risk-Taking; D018139:Simplexvirus / Q000302:isolation & purification; D016896:Treatment Outcome
D000212:Acyclovir